Norwegian Finans Holding ASA
4.3.2021 11:02:16 CET | Globenewswire | Press release
The Board of Directors in Norwegian Finans Holding ASA ("the Company") refers to the announcement at 08.00 CET at 4 March, where Nordax Bank AB announces its intention to launch a voluntary offer for the shares in the company. The Board of Directors will consider any offer launched. Shareholders are advised to refrain from taking any action in respect of their shares in the Company, before the Board of Directors has given their recommendation, and to exercise caution when dealing in the shares of the Company. Such actions may be prejudicial to shareholders interests. There can be no certainty that any offer will be made or completed. Further announcements will be made as required.
For any questions please call:
Klaus-Anders Nysteen, Chairman of the Board of Directors, phone: +47 99 26 56 91 / + 46 72-566 54 15
Tine Wollebekk, CEO, phone: +47 40 80 55 57
Klara-Lise Aasen, CFO, phone: +47 47 63 55 83
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
Teva Pharmaceutical Industries Ltd18.9.2026 22:31:00 CEST | Press release
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
Teva Pharmaceutical Industries Ltd18.9.2026 22:30:00 CEST | Press release
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Leading Edge Materials Corp.18.9.2026 20:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2026 AND ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT
Orion Oyj18.9.2026 18:00:00 CEST | Press release
Orion Corporation: Acquisition of own shares during week 38, 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
